Diurnal variation and effect of insulin on circulating high molecular weight (HMW) adiponectin and NF-κB activity in human endothelial cells

Atherosclerosis

Volumn 214, Issue 1, 2011, Pages 174-177

  Tan, Bee K ^a,b   Adya, Raghu ^a   Lewandowski, Krzysztof C ^a,c   O'Hare, J Paul ^a   Randeva, Harpal S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Adipokine; Adiponectin; Atherosclerosis; Diabetes; NF B

Indexed keywords

ADIPONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; GLUCOSE INFUSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN INFUSION; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR WEIGHT; NORMAL HUMAN; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; MICROCIRCULATION; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; NF-KAPPA B; OBESITY;

EID: 78650838965     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.10.013     Document Type: Article

References (13)

1. Missiou A., Wolf D., Platzer I., et al. CD40L induces inflammation and adipogenesis in adipose cells-a potential link between metabolic and cardiovascular disease. Thromb Haemost 2010, 103:788-796.
2. Hattori Y., Nakano Y., Hattori S., et al. High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells. FEBS Lett 2008, 582:1719-1724.
3. Zhang P., Wang Y., Fan Y., Tang Z., Wang N. Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells. Arterioscler Thromb Vas Biol 2009, 29:67-74.
4. Basu R., Pajvani U.B., Rizza R.A., Scherer P.E. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 2007, 56:2174-2177.
5. Blümer R.M., van der Crabben S.N., Stegenga M.E., et al. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans. Am J Physiol Endocrinol Metab 2008, 295:E613-E617.
6. Cavusoglu E., Ruwende C., Chopra V., et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006, 27:2300-2309.
7. Hada Y., Yamauchi T., Waki H., et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun 2007, 356:487-493.
8. Fujimatsu D., Kotooka N., Inoue T., Nishiyama M., Node K. Association between high molecular weight adiponectin levels and metabolic parameters. J Atheroscler Thromb 2009, 16:553-559.
9. Lewandowski K., Randeva H.S., O'Callaghan C.J., et al. Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin. Clin Endocrinol (Oxf) 2001, 54:533-539.
10. Fukushima Y., Tamura M., Nakagawa H., Itoh K. Induction of glioma cell migration by vitronectin in human serum and cerebrospinal fluid. J Neurosurg 2007, 107:578-585.
11. Chen J., Tan B., Karteris E., et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006, 49:1292-1302.
12. Angleton P., Chandler W.L., Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989, 79:101-106.
13. Hattori Y., Hattori S., Kasai K. Globular adiponectin activates nuclear factor-kappaB in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. Diab Care 2006, 29:139-141.